leisure time -WSS

leisure time

author：leisure time 2025-10-01 21:40:02 - browse：6155

BIO is proceeding with a restructuring after its new CEO took over. Lane Turner/The Boston Globe

WASHINGTON — The Biotechnology Innovation Organization on Monday is announcing a significant restructuring accompanied by a shakeup, according to five sources familiar with the planning.

A few senior leaders are expected to depart as part of the reorganization. Chief Science Officer Cartier Esham, Chief Public Affairs and Marketing Officer Rich Masters, and Chief Policy Officer John Murphy are expected to leave, four sources said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： GOP inquiry over gain

hotspot

WSS

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Supreme Court rules employers must be more accommodating of religious observance

Eating disorder hotline's move to chatbot carried cost for volunteers

Biotech lab space demand falls sharply

Why are Kaiser Permanente staff considering a strike?

Ukraine and a new approach to mental health in war

knowledge

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Drug repurposing or repositioning? The language matters

Medical student insurance fails on mental health care coverage

Psychedelics group wrestles with new pharma identity

Here's how to stay safe from wildfire smoke amid reduced air quality

BioMarin wins approval for gene therapy to treat hemophilia A

Changes to biosimilar regulatory framework must prioritize patients

Psychedelics group wrestles with new pharma identity

Supreme Court rules employers must be more accommodating of religious observance

Psychedelics group wrestles with new pharma identity

Medical student insurance fails on mental health care coverage

focus

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Readout LOUD podcast: possible new ALS drug, artificial wombs

What Congress can do to address the rural doctor shortage

Eating disorder hotline's move to chatbot carried cost for volunteers

Brazil's Jair Bolsonaro is barred from running for office until 2030

Biotech lab space demand falls sharply

focus

leisure time

hotspot

entertainment